The global Drug Testing market was valued at USD 5.3 billion in 2021 and is projected to reach USD 9.45 billion in 2029, at a Compound Annual Growth Rate (CAGR) of 7.5 % during the forecast period 2022-2029.

A drugs test, sometimes likewise alluded to as drugs screening, is any test administered for the technical analysis of biological specimens of the human body, to detect the presence, or in some cases any earlier use, of illicit drugs or their metabolites. A metabolite is essentially a parent drug's metabolised, inactive form. For instance, these tests are usually compulsory under various scenarios such as job applications, random employee testing, police investigations, etc.

There are different types of drug testing devices such asanalyzers devices, rapid testing devices, and consumables. By Sample types, the market is segmented into Saliva, Sweat, Hair, Urine, Blood, and, Others. Additionally, there are several applications of these drug testing instruments such as Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centres, Individual Users, Pain Management Centres, Schools and Colleges, and others. This report emphasises the type, sample type, and application of Drug Testing in different regions and countries over the forecast period.

Source: Marketlook Consulting

Global Drug Testing Market Overview

The global Drug Testing Market demand is driven by the growth of the healthcare sector. For instance, Stringent regulations by government agencies mandating drug testing for safety purposes and increasing drives to monitor and battle substance abuse are anticipated to support the market growth. Also, rising regulatory approvals for drug screening products & services which has propelled the demand for drug testing.

Drug Testing Market Dynamics

Illicit drug use is rising worldwide. As per the World Drug Report 2021, in 2019, an estimated 275 million people worldwide aged 15–64, or 1 in every 18 individuals in that age bunch, have used drugs at least once in the earlier year (range: 175 million to 374 million). In 2019, 36.3 million people, or around 13% of the global population, were assessed to be suffering from drug use disorders. In the same year, drug use killed around half a million people, while drug use disorders resulted in 18 million years of healthy life lost, primarily due to opioids. The rising consumption of illicit drugs & alcohol will further increase the development of drug screening products & services on the road, thereby driving the overall market growth.

Additionally, fingerprint-based drug testing is a new idea that has gained importance because of the COVID-19 pandemic. The coronavirus has made it difficult to execute drug testing in medical clinics, labs, and other facilities because of the risk of transmitting the infection. It is non-invasive, portable, less time-consuming, hygienic, enables social distancing, is user-friendly, and requires no specific preparation for sample collection and handling. This test is extremely simple to execute whenever and wherever required, thus offering flexible and effective workplace drug testing. The test analyzes small traces of sweat in the fingerprint to detect drug and drug metabolites. This test is used in workplaces, law enforcement, criminal justice, and drug rehabilitation programs. If this test is broadly embraced, it is expected to replace urine, hair, and blood-based drug tests. This is a significant opportunity for the market players to benefit from the drug screening market.

Source: Marketlook Consulting

However, the right to privacy and prohibition of drug and alcohol testing in a few nations are likely to be major factors hampering the market growth. In many European countries, like Finland and Belgium, in contrast to the U.S., there are rigid privacy rights that cannot be ignored while evaluating for substance abuse. In Netherlands, pre-employment substance abuse screening is illegal. Numerous European countries issue penalties for unjustified testing, with criminal fines. This is considered a breach of workers’ privacy. Hence, such severe privacy rights are likely to restrict testing at workplaces, limiting market growth over the forecast period.

Drug Testing Market Report Outlook

The Drug Testing market report focuses on different aspects regarding the type of Drug Testing, sample types, and across the different applications used in the Healthcare sector. The research analyses the different types, sample types, and applications of the product in order to obtain a better understanding of the growth and trends of the market since 2019 which also facilitates the estimation of the upcoming growth of the market in the next 7 years.

Drug Testing Market Competitive Landscape

The report also holds competitive analysis which can be used to differentiate different types of products; technologies used in manufacturing the products; prices; innovation in R&D; organic and inorganic growth strategies; financial analysis to determine the revenue generation and other key aspects of the finance; new partnership, joint ventures, collaborations, and acquisitions; market share of the top competitors in the market; and understand the growth strategies being undertaken by these major players to analyse the future market trends.

Major companies such as Abbott Laboratories in August 2019 partnered with Intoximeters, allowing Intoximeters to market Abbott's SoToxaTM Mobile Test System which is a handheld solution for oral fluid roadside testing. It has been designed to allow quick detection of recent drug use. Additionally, in August 2022 Shimadzu announces the release of the Luminous Quester NI near-infrared imaging system contributing to Drug Discovery Research.

Other major players holding prominent share in the Drug Testing market include Premier Biotech, Alfa Scientific Designs, OraSure Technologies, Drägerwerk, LifeLock,Thermo Fisher Scientific, MPD Inc., Omega Laboratories, Psyche medics, Roche, and Siemens Healthineers, and Quest Diagnostics. There are several regional and local players in this market across the globe which are contributing to the revenue growth of the market and thus expected to flourish with new launches and expansion in the upcoming years.

Drug Testing Market Regional Analysis

The market synopsis will also cover the regional dynamics and growth prospects which would include regions- North America, Asia Pacific, Europe, Latin America, Middle East and Africa. These regions will be analysed per country on the basis of market drivers, restraints, opportunities, and trends to get a closer view of the market studied.

Moreover, in 2021 North America accounts for the largest share of the drug abuse testing market globally. The rising prevalence of opioid dependence in the U.S. is expected to continue boosting demand for drug testing tools over the forecast period. Drug abuse rates during the COVID-19 pandemic have grown significantly in the country, with more individuals getting dependent on cannabinoids for stress and anxiety relief. As per the National Centre for Drug Abuse Statistics, 53 million people beyond the age of 12 have used illegal drugs or misused prescription drugs in 2020.New organ-on-a-chip platforms enable a more accurate perception of drug effects on the human body, and its headways are likewise adding to the growth of the North American drug screening market.

Authorities are forced to launch drug testing protocols due to the rising use of legal substances, primarily liquor, and the use of Class A drugs including heroin, meth, cocaine, and other hallucinogens. Furthermore, due to the rising demand for drug abuse screening from emerging economies, Asia Pacific is predicted to experience lucrative growth over the forecast period. The demand for drug testing in these nations has increased due to the rising prevalence of substance abuse disorders, drug-related crimes, and deadly road accidents. The Harm Reduction Consortium published the first edition of the Global Drug Policy Index in November 2021, ranking India 18th out of 30 nations. The top 5 countries on the index were Norway, New Zealand, Portugal, the United Kingdom (UK), and Australia.

Drug Testing Market In-depth Analysis Aspects

To mention certain other aspects which will include the Porter Five Forces, Pricing analysis, PESTEL Analysis, Export-Import data, and Industry Value Chain will also bind the analysis of the report.

Research Methodology

The study period of the market is considered to be 10 years (2019-2029) which will be analysed through the two major research techniques – Primary and Secondary Research methods. The primary research method includes the interviews of the key personnel in the industry considered as the industry experts, major distributors, suppliers, and consumer base sample survey to understand the direct perspective of the market. Additionally, these data are backed by the secondary research method which includes company overview through websites, annual reports, SEC filings, investor presentations, news, and databases. The growth trends are always measured on the basis of current and past scenarios considering any recent news which can drastically impact the growth rate of the market studied. Moreover, the consumption forecast depends on the company’s upcoming plans and revenue generation aspects.

Benefits of The Report

  • The report is designed to understand the past, present, and future market scenarios considering all the growth, restraining, and other factors influencing the market studied.
  • The report is designed with the assistance of the industry experts for a better understanding on the market studied
  • The market is analysed with an in-depth study of the company’s view on the market considering the present economical, political, social, geographical, and legal factors.
  • To gain a clear insight for a better future perspective of the market studied in 360-degree synopsis.
  • Understand the competition in the market being a part of the market or a new entrant in the market.
  • Analyse the different aspects in different geographies influencing the growth of the market through a diverse consumer base.

 

Table Of Content

1. Market Overview

1.1 Research Methodology

1.2 Definitions and Scope

2. Market - Executive Summary

2.1 Market Opportunity

2.2 Key Trends by Product Segments

2.3 Key Trends by Geography

3. Drug Testing Market Landscape

3.1 Comparative analysis

3.1.1 Product Benchmarking - Top 10 companies

3.1.2 Top 5 Financials Analysis

3.1.3 Market Value split by Top 10 companies

3.1.4 Pricing Analysis

4. Market Forces

4.1 Market Drivers

4.1.1 Rising illicit drug use

4.1.2 Fingerprint Drug Testing is gaining importance after COVID-19

4.2 Market Constraints

4.2.1 Prohibition on workplace drug testing in some countries

4.2.2 Other Constraints

4.3 Market Challenges

4.5 Porter’s Five Forces

4.5.1 Bargaining Power of Suppliers

4.5.2 Bargaining Power of Consumers

4.5.3 Threat of New Entrants

4.5.4 Threat of Substitute Products and Services

4.5.5 Degree of Competition

5. Drug Testing Market - Strategic Analysis

5.1 Value Chain

5.2 Opportunity

5.3 Pricing Analysis

5.4 Export-Import Analysis

6. Global Drug Testing Market Outlook

6.1 Global Drug Testing Market Outlook, by Type, 2019-2029

6.1.1 Analyzers

6.1.1.1 Immunoassay analyzers

6.1.1.2 Chromatographic devices

6.1.1.3 Breath analysers

6.1.2 Rapid Testing Devices

6.2.2.1 Urine testing

 6.2.2.2 Oral fluid testing

 6.1.3 Consumables

6.2 Global Drug Testing Market Outlook, by Sample Type, 2019-2029

6.2.1 Urine

6.2.2 Sweat

6.2.3 Hair

6.2.4 Saliva

6.2.5 Blood

6.2.6 Others

6.3 Global Drug Testing Market Outlook, by Application, 2019-2029

 6.3.1 Laboratories

 6.3.2 Workplaces

 6.3.3 Criminal Justice and Law Enforcement Agencies

 6.3.4 Drug Treatment Centres

 6.3.5 Individual Users

 6.3.6 Hospitals

 6.3.7 Pain Management Centres

 6.3.8 Schools and Colleges

 6.3.9 Others

7. Asia Pacific Drug Testing Market Outlook

7.1 Key Snapshot

7.2 Asia Pacific Drug Testing Market Outlook, by Type, 2019-2029

7.2.1 Analyzers

7.2.1.1 Immunoassay analyzers

7.2.1.2 Chromatographic devices

7.2.1.3 Breath analysers

7.2.2 Rapid Testing Devices

7.2.2.1 Urine testing

7.2.2.2 Oral fluid testing

7.2.3 Consumables

7.3 Asia Pacific Drug Testing Market Outlook, by Sample Type, 2019-2029

 7.3.1 Urine

 7.3.2 Sweat

 7.3.3 Hair

 7.3.4 Saliva

 7.3.5 Blood

 7.3.6 Others

7.4Asia Pacific Drug Testing Market Outlook, by Application, 2019-2029

 7.4.1 Laboratories

 7.4.2 Workplaces

 7.4.3 Criminal Justice and Law Enforcement Agencies

 7.4.4 Drug Treatment Centres

 7.4.5 Individual Users

 7.4.6 Hospitals

 7.4.7 Pain Management Centres

 7.4.8 Schools and Colleges

 7.4.9 Others

7.5 Asia Pacific Drug Testing Market Outlook, by Country, 2019-2029

7.5.1 China Drug Testing Market Outlook, 2019-2029

7.5.2 India Drug Testing Market Outlook, 2019-2029

7.5.3 Japan Drug Testing Market Outlook, 2019-2029

7.5.4 South Korea Drug Testing Market Outlook, 2019-2029

7.5.5 Australia Drug Testing Market Outlook, 2019-2029

7.5.6 Rest of Asia Pacific Drug Testing Market Outlook, 2019-2029

8. North America Drug Testing Market Outlook

8.1 Key Snapshot

8.2 North America Drug Testing Market Outlook, by Type, 2019-2029

8.2.1 Analyzers

8.2.1.1 Immunoassay analyzers

8.2.1.2 Chromatographic devices

8.2.1.3 Breath analysers

8.2.2 Rapid Testing Devices

8.2.2.1 Urine testing

8.2.2.2 Oral fluid testing

8.2.3 Consumables

8.3 North America Drug Testing Market Outlook, by Sample Type, 2019-2029

 8.3.1 Urine

 8.3.2 Sweat

 8.3.3 Hair

 8.3.4 Saliva

 8.3.5 Blood

 8.3.6 Others

8.4 North America Drug Testing Market Outlook, by Application, 2019-2029

 8.4.1 Laboratories

 8.4.2 Workplaces

 8.4.3 Criminal Justice and Law Enforcement Agencies

 8.4.4 Drug Treatment Centres

 8.4.5 Individual Users

 8.4.6 Hospitals

 8.4.7 Pain Management Centres

 8.4.8 Schools and Colleges

 8.4.9 Others

8.5 North America Drug Testing Market Outlook, by Country, 2019-2029

8.5.1 United States Drug Testing Market Outlook, 2019-2029

8.5.2 Canada Drug Testing Market Outlook, 2019-2029

8.5.3 Mexico Drug Testing Market Outlook, 2019-2029

9. Europe Drug Testing Market Outlook

9.1 Key Snapshot

9.2 Europe Drug Testing Market Outlook, by Type, 2019-2029

9.2.1 Analyzers

9.2.1.1 Immunoassay analyzers

9.2.1.2 Chromatographic devices

9.2.1.3 Breath analysers

9.2.2 Rapid Testing Devices

9.2.2.1 Urine testing

9.2.2.2 Oral fluid testing

9.2.3 Consumables

9.3 Europe Drug Testing Market Outlook, by Sample Type, 2019-2029

9.3.1 Urine

9.3.2 Sweat

9.3.3 Hair

9.3.4 Saliva

9.3.5 Blood

9.3.6 Others

9.4 Europe Drug Testing Market Outlook, by Application, 2019-2029

9.4.1 Laboratories

9.4.2 Workplaces

9.4.3 Criminal Justice and Law Enforcement Agencies

9.4.4 Drug Treatment Centres

 9.4.5 Individual Users

 9.4.6 Hospitals

 9.4.7 Pain Management Centres

 9.4.8 Schools and Colleges

 9.4.9 Others

9.5 Europe Drug Testing Market Outlook, by Country, 2019-2029

9.5.1 United Kingdom Drug Testing Market Outlook, 2019-2029

9.5.2 Germany Drug Testing Market Outlook, 2019-2029

9.5.3 France Drug Testing Market Outlook, 2019-2029

9.5.4 Italy Drug Testing Market Outlook, 2019-2029

9.5.5 Spain Drug Testing Market Outlook, 2019-2029

9.5.6 Rest of Europe Drug Testing Market Outlook, 2019-2029

10. Latin America Drug Testing Market Outlook

10.1 Key Snapshot

10.2 Latin America Drug Testing Market Outlook, by Type, 2019-2029

10.2.1 Analyzers

10.2.1.1 Immunoassay analyzers

10.2.1.2 Chromatographic devices

10.2.1.3 Breath analysers

10.2.2 Rapid Testing Devices

10.2.2.1 Urine testing

10.2.2.2 Oral fluid testing

10.2.3 Consumables

10.3 Latin America Drug Testing Market Outlook, by Sample Type, 2019-2029

 10.3.1 Urine

 10.3.2 Sweat

 10.3.3 Hair

 10.3.4 Saliva

 10.3.5 Blood

 10.3.6 Others

10.4 Latin America Drug Testing Market Outlook, by Application, 2019-2029

 10.4.1 Laboratories

 10.4.2 Workplaces

 10.4.3 Criminal Justice and Law Enforcement Agencies

 10.4.4 Drug Treatment Centres

 10.4.5 Individual Users

 10.4.6 Hospitals

 10.4.7 Pain Management Centres

 10.4.8 Schools and Colleges

 10.4.9 Others

10.5 Latin America Drug Testing Market Outlook, by Country, 2019-2029

10.5.1 Brazil Drug Testing Market Outlook, 2019-2029

10.5.2 Argentina Drug Testing Market Outlook, 2019-2029

10.5.3 Rest of Latin America Drug Testing Market Outlook, 2019-2029

11. Middle East and Africa Drug Testing Market Outlook

11.1 Key Snapshot

11.2 Middle East and Africa Drug Testing Market Outlook, by Type, 2019-2029

11.2.1 Analyzers

11.2.1.1 Immunoassay analyzers

11.2.1.2 Chromatographic devices

11.2.1.3 Breath analysers

11.2.2 Rapid Testing Devices

11.2.2.1 Urine testing

11.2.2.2 Oral fluid testing

11.2.3 Consumables

11.3 Middle East and Africa Drug Testing Market Outlook, by Sample Type, 2019-2029

 11.3.1 Urine

 11.3.2 Sweat

 11.3.3 Hair

 11.3.4 Saliva

 11.3.5 Blood

 11.3.6 Others

11.4 Middle East and Africa Drug Testing Market Outlook, by Application, 2019-2029

 11.4.1 Laboratories

 11.4.2 Workplaces

 11.4.3 Criminal Justice and Law Enforcement Agencies

 11.4.4 Drug Treatment Centres

 11.4.5 Individual Users

 11.4.6 Hospitals

 11.4.7 Pain Management Centres

 11.4.8 Schools and Colleges

 11.4.9 Others

11.5 Middle East and Africa Drug Testing Market Outlook, by Country, 2019-2029

11.5.1 Saudi Arabia Drug Testing Market Outlook, 2019-2029

11.5.2 UAE Drug Testing Market Outlook, 2019-2029

11.5.3 South Africa Drug Testing Market Outlook, 2019-2029

11.5.4 Rest of Middle East and Africa Drug Testing Market Outlook, 2019-2029

12. Drug Testing Market -Entropy

12.1 New Product Launches

12.2 M&A, Collaborations, JVs, and Partnerships

13. Drug Testing Market Company Analysis

13.1 Market Share Analysis, Financial Analysis, Product Synopsis, Recent News, and Developments

13.2 Premier Biotech

13.3 Alfa Scientific Designs

13.4 OraSure Technologies

13.5 Drägerwerk

13.6 LifeLock

13.7 Thermo Fisher Scientific

13.8 MPD Inc.

13.9 Omega Laboratories

13.10 Psychemedics

13.11 Abbott Laboratories

13.12 Shimadzu

Top Major Players List :- Drug Testing Market

  • Premier Biotech
  • Alfa Scientific Designs
  • OraSure Technologies
  • Drägerwerk
  • LifeLock
  • Thermo Fisher Scientific
  • MPD Inc.
  • Omega Laboratories
  • Psychemedics
  • Abbott Laboratories
  • Shimadzu
FAQ

The market value is estimated to stand around USD 9.45 billion in 2029

Stringent regulations by government agencies mandating alcohol and drug testing for safety purposes & increasing initiatives to monitor and combat substance abuse

Quest Diagnostics Inc., LabCorp, Drägerwerk & Abbott Laboratories

Types, Sample Types & Application of Drug Testing Equipment

Technological innovation and Fingerprint based Drug Testing

SELECT LICENCE TYPE

  • Single User Licence     $2950
  • Multi User Licence     $4950
  • Enterprice User Licence     $6950